BioStem Technologies Announces Issuance of Four U.S. Design Patents Covering Fenestrated Human Placental Allograft Technologies
BioStem Technologies secured four U.S. design patents covering its fenestrated human placental allograft technologies, specifically protecting designs aimed at improving fluid management and conformability in wound care. The issuance expands the company's intellectual property portfolio, which now includes more than 100 patents and patent applications worldwide.
Key figures
- Patent numbers
- ["D1131805","D1130758","D1130759","D1130760"]
- New patent count
- 4
- Total patents and applications
- more than 100
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.